Supriya Lifescience has informed that Board of Directors of Company at its meeting held on January 21, 2022, has considered and approved the Unaudited Financial Results of the for the Quarter and nine months ended December 31, 2021 along with the Limited Review Report. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (Listing Regulations), the company enclosed a copy of the above mentioned Unaudited Financial Results along with the Limited Review Report of the Auditors. The Financials Results will be published in newspapers as required under the Listing Regulations. The Meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 12.25 pm.
The above information is a part of company’s filings submitted to BSE.